Rittler Peter, Schiefer Beatrice, Demmelmair Hans, Koletzko Berthold, Vogeser Michael, Alpers David H, Jauch Karl-Walter, Hartl Wolfgang H
Department of Surgery, Department of Clinical Chemistry, Klinikum Grosshadern, Marchioninistrasse 15, D-81377 Munich, Germany.
JPEN J Parenter Enteral Nutr. 2006 Mar-Apr;30(2):97-107. doi: 10.1177/014860710603000297.
Hyperglycemic hyperinsulinemia cannot stimulate intestinal protein synthesis in healthy individuals but does so in conditions characterized by an altered somatotropic axis such as diabetes. Only in a state of growth hormone resistance (high growth hormone but low insulin like growth factor [IGF-1] concentrations), extra insulin may acutely reverse the impaired, growth-hormone-induced IGF-1 release, thereby exerting anabolic actions at the intestinal tract. Growth hormone resistance can be also found in patients after surgical stress. Therefore, we wanted to test the hypothesis whether hyperglycemic hyperinsulinemia would stimulate ileal protein synthesis in the latter condition. Mass spectrometry techniques (capillary gas chromatography/combustion isotope ratio mass spectrometry) were used to directly determine the incorporation rate of 1-[(13)C]-leucine into ileal mucosal protein. All subjects had an ileostomy, which allowed easy access to the ileal mucosa, and consecutive sampling from the same tissue was performed during continuous isotope infusion (0.16 mumol/kg min). Isotopic enrichments and fractional protein synthesis were determined at baseline (period I) and after a 4-hour glucose infusion (170 mg/kg/h) or after infusion of saline (control group) (period II). In controls, ileal protein synthesis declined significantly during prolonged isotope infusion (period I: 1.11 +/- 0.14%/h, period II: 0.39 +/- 0.13%/h, p < .01). In contrast, ileal protein synthesis remained constant during glucose infusion (period I: 1.32 +/- 0.35%/h, period II: 1.33 +/- 0.21%/h, n.s. vs period I, but p < .005 vs the corresponding value at the end of period II in the control group). Using the continuous tracer infusion technique, ileal protein synthesis seemingly declines over a short time in control subjects. We found evidence that this artificial decline was due to mass effects of a rapidly turning over mucosa protein pool in which an isotopic plateau was reached during the experiment and of which the size amounted to approximately 4% of the total mixed protein pool. Maintenance of ileal protein synthesis during glucose infusion therefore indicates a rise of ileal protein synthesis in a slowly turning over protein pool. This effect in postsurgical patients would be compatible with the concept of intestinal insulin action to depend on the specific clinical state (eg, growth hormone resistance).
高血糖高胰岛素血症在健康个体中无法刺激肠道蛋白质合成,但在诸如糖尿病等生长激素轴改变的情况下却能刺激肠道蛋白质合成。只有在生长激素抵抗状态(高生长激素但低胰岛素样生长因子[IGF-1]浓度)下,额外的胰岛素可能会急性逆转受损的、生长激素诱导的IGF-1释放,从而在肠道发挥合成代谢作用。生长激素抵抗也可见于手术应激后的患者。因此,我们想检验高血糖高胰岛素血症在后者情况下是否会刺激回肠蛋白质合成这一假设。采用质谱技术(毛细管气相色谱/燃烧同位素比率质谱法)直接测定1-[(13)C]-亮氨酸掺入回肠黏膜蛋白的速率。所有受试者均行回肠造口术,这便于获取回肠黏膜,并且在持续同位素输注(0.16 μmol/kg·min)期间对同一组织进行连续采样。在基线期(I期)以及葡萄糖输注4小时后(170 mg/kg/h)或输注生理盐水后(对照组)(II期)测定同位素富集和蛋白质合成分数。在对照组中,在长时间同位素输注期间回肠蛋白质合成显著下降(I期:1.11±0.14%/h,II期:0.39±0.13%/h,p<0.01)。相比之下,在葡萄糖输注期间回肠蛋白质合成保持恒定(I期:1.32±0.35%/h,II期:1.33±0.21%/h,与I期相比无统计学差异,但与对照组II期末的相应值相比p<0.005)。使用连续示踪剂输注技术,对照组受试者的回肠蛋白质合成在短时间内似乎下降。我们发现证据表明这种人为下降是由于快速周转的黏膜蛋白池的质量效应,在实验期间该蛋白池达到了同位素平台期,其大小约占总混合蛋白池的4%。因此,葡萄糖输注期间回肠蛋白质合成的维持表明在周转缓慢的蛋白池中回肠蛋白质合成增加。手术患者中的这种效应与肠道胰岛素作用取决于特定临床状态(如生长激素抵抗)的概念相符。